Technology

Recombinant Vaccine Against Lawsonia Intrecellularis

APTAAgropecuario

Vaccine against Lawsonia intracellularis based on a recombinant synthetic chimeric variant of membrane proteins and invasins of said bacterium.

Advantages

– Safer: the components only contain recombinant peptides, without the involvement of virulence factors.
– Healthier: do not induce side effects at the injection sites.
– Cheaper: efficient manufacture, purification and characterization, and inexpensive to enable widespread use.

Agenda una reunión con nosotros

Completa el formulario O llama al + 56 9 4065 5017

Suscríbete a nuestro briefing

Al enviar tus datos, aceptas nuestros términos y condiciones para recibir nuestros contenido.